Charlotte's Web (CWBHF) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
24 Dec, 2025Executive summary
Achieved consecutive quarterly revenue growth in 2024, reversing a multi-year decline, with Q4 revenue of $12.7M, up from Q3 2024.
Reduced operating expenses by $22.4M year-over-year, improving operational efficiency and cash flow.
Upgraded e-commerce platform and omnichannel strategy drove improved performance, with e-commerce excelling during the holiday season.
Expanded product portfolio with successful launches in functional mushroom and CBN sleep gummies, and new partnerships with Walmart and Chewy.com.
Announced rebranding initiative to unify all products under a single identity, enhancing marketing and retail presence.
Financial highlights
Q4 2024 net revenue was $12.7M, down 20% year-over-year but up sequentially; full-year revenue was $49.7M, down 21.4%.
Q4 gross profit was $5.1M (40.2% margin), down from $8.9M (56.0%) in Q4 2023 due to promotions and shipping inefficiencies.
Q4 SG&A expenses reduced by $8M (43.3%) year-over-year, to $10.6M; full-year SG&A: $53.3M, down 29.6%.
Q4 net loss was $3.4M ($0.02/share), a $5.1M improvement from prior year; full-year net loss was $29.8M ($0.19/share).
Adjusted EBITDA for Q4 was positive $0.3M, a $6.8M improvement year-over-year; full-year adjusted EBITDA loss improved to $12.6M from $22.7M.
Ended 2024 with $22.6M in cash reserves; Q4 cash burn reduced to $1.8M; working capital: $31.1M.
Outlook and guidance
Targeting gross margin above 50% for 2025 as in-house production increases.
Anticipates significant reduction in cash burn in 2025 due to lower CapEx and full-year impact of cost savings.
Strategic focus on year-over-year growth in 2025, leveraging operational improvements and expanded product offerings.
Launch of functional mushroom gummies on Amazon.com expected to diversify revenue and expand reach.
Latest events from Charlotte's Web
- Sequential revenue growth and cost cuts support breakeven and turnaround progress.CWBHF
Q2 20242 Feb 2026 - Virtual meeting to elect six directors, appoint auditors, and advance ESG and governance initiatives.CWBHF
Proxy Filing2 Dec 2025 - Vote on six directors, board size, and auditor appointment at the June 2025 virtual meeting.CWBHF
Proxy Filing2 Dec 2025 - Q2 2025 saw 4.2% revenue growth, margin gains, and a 43% lower net loss, with cost savings fueling momentum.CWBHF
Q2 202523 Nov 2025 - Revenue dropped 8.6% as B2B changes and cost cuts set up margin recovery in 2026.CWBHF
Q3 202517 Nov 2025 - Sequential growth, cost cuts, and new products drive improved results amid regulatory headwinds.CWBHF
Q3 202413 Jun 2025 - Revenue up 1.1%, net loss narrows, and $18M in future payments waived after MLB deal ends.CWBHF
Q1 20256 Jun 2025